Search | Médecins Sans Frontières Access Campaign

2443 results found

Hassan Abdedine, vaccinator of the Ministry of Public Health of Chad, on a vaccination site set up by MSF teams in Dini, Batha province, Chad.

Press release |

15 April 2024

As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination

With routine vaccination efforts failing to reach people in fragile and emergency settings, MSF is seeing low vaccination coverage and more outbreaks of vaccine-preventable diseases, like diphtheria and measles

Tags Vaccines Gavi, the Vaccine Alliance

Letter |

08 April 2024

Americas TB Coalition letter to Danaher to reduce the price of GeneXpert test

Letter from the Americas TB Coalition to Danaher and Cepheid to reduce the price of the XDR-TB test

Tags DiagnosticsTuberculosis

Letter |

02 April 2024

Sierra Leone: National TB Programme letter to Danaher to reduce the price of GeneXpert test

Letter from the national TB programme of Sierra Leone to Danaher and Cepheid to reduce the price of the XDR-TB test

Tags DiagnosticsTuberculosis tuberculosis Sierra Leone

Letter |

02 April 2024

Belarus: National TB Programme letter to Danaher to reduce the price of GeneXpert test

Letter from the national TB programme of Belarus to Danaher and Cepheid to reduce the price of the XDR-TB test

Tags DiagnosticsTuberculosis Belarus

Infographic

Ebola treatments: How to make them accessible

Marking 10 years since the world’s deadliest Ebola outbreak on record, which killed more than 11,000 people in West Africa in 2014-2016, MSF provides this visual explainer about the currently available treatments for Ebola, and what is ...

Tags Tropical & neglected diseases

Medical staff providing treatment in MSF-supported Bolomba Ebola treatment center, Equateur province, DRC, August 2020

Press release |

18 March 2024

MSF calls for emergency stockpile of Ebola treatments ten years after world’s deadliest outbreak

Ten years after West Africa Ebola outbreak, MSF calls for global emergency stockpile of Ebola treatments

Tags Tropical & neglected diseases

6th October 2010: Wednesday in New Delhi, patients and activists stage a DIE-IN to protest at talks today between the European Union and the Indian government over a free trade agreement that could end production of life-saving affordable medicines for millions in need in developing countries.

Press release |

12 March 2024

MSF response to signing of EFTA-India trade agreement

Certain clauses in the trade deal could dilute use of public health measures under Indian patent law.

Tags Intellectual property and trade free trade agreementTRIPS SwitzerlandIndia

Thousands of demonstrators took to the streets in Delhi once again on 2 March 2011, in protest over the planned Free Trade Agreement between India and the European Union (EU) which will restrict access to life-saving medicines.Thousands of demonstrators took to the streets in Delhi once again on 2 March in protest over the planned Free Trade Agreement between India and the European Union (EU) which will restrict access to life-saving medicines.

Technical brief |

12 March 2024

MSF Comments on intellectual property provisions in the final agreement of India-EFTA Agreement

MSF technical analysis shares problematic clauses in EFTA India FTA trade agreement

Tags Intellectual property and trade free trade agreement SwitzerlandIndia

Letter |

05 March 2024

Letter: Civil society calls on European Parliament to support global access to medical tools by removing export prohibition in Union compulsory license

MSF and CSOs call for European support of access to medical tools through Union compulsory license

Tags Intellectual property and trade

A close-up photo shows pills in the hand of an MDR TB patient taking his Direct Observation Treatment Short Course (DOTs) medication at the Nhlangano TB Ward supported by MSF.

Press release |

29 February 2024

EU must drop all intellectual property provisions that go beyond WTO requirements in trade negotiations with India, as recommended in today’s SIA report

Millions of people around the world rely on affordable generic medicines and vaccines produced in India, the ‘Pharmacy of the Developing World’

Tags Intellectual property and trade free trade agreementTRIPS

Technical brief |

22 February 2024

The PASTEUR Act is not the way for the US government to address antimicrobial resistance

The US PASTEUR Act falls short in addressing antimicrobial resistance

Tags Antimicrobial resistance

Round of medical staff in the Covid-19 patients ward, Yaoundé, Cameroon.

Statement |

18 February 2024

Pandemic Accord: MSF statement at INB8 plenary session

MSF statement on pandemic accord draft text at INB8

Tags Pandemic preparednessIntellectual property and trade

Press release |

15 February 2024

MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions

MSF welcomes the Indian Commerce Ministry’s strong stand against the inclusion of data exclusivity in its free trade agreement talks with the European Free Trade Association (EFTA).

Tags Intellectual property and trade India

Press release |

14 February 2024

Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is

Leaked text shows India-EFTA trade deal includes excessive intellectual property provisions that may require India to gut pro-public health national laws, which may undermine people's access to affordable medicines from India

Tags Intellectual property and trade European Free Trade Association India

Maria Atonio, 43-years-old farmer from Macomia, returns home after visiting MSF’s Clinic in Nanga to receive ART treatment and to have a medical appointment with MSF’s clinical officer to monitor her health.

Press release |

06 February 2024

Colombia takes significant next step to expand people’s access to affordable HIV treatment, and moves forward with compulsory license for HIV medicine dolutegravir

MSF welcomes Colombia taking a historic next step towards issuing first-ever compulsory license to increase access to more affordable generic versions of key HIV medicine dolutegravir

Tags HIV/AIDS HIV/AIDS Medicines Patent PoolWorld Health OrganizationViiV

Children living with TB are a vulnerable and neglected group. In 2022, an estimated 1.25 million children and young adolescents fell ill with tuberculosis (TB), and more than 200,000 children died – that’s 1 death every 3 minutes.

Fact sheet |

24 January 2024

Diagnosing Paediatric TB: Challenges and Needs

We desperately need more research and development for TB diagnostics that are specifically designed for children

Tags Tuberculosis tuberculosis

Goma, North Kivu province in the Democratic Republic of Congo (DRC), multi-antigen vaccination campaign.

Statement |

22 January 2024

MSF statement on EB 154/9 - Immunization Agenda 2030

If promoting equity to benefit the most excluded communities is truly a priority for the Immunization Agenda 2030, then efforts to reach the millions of children living in humanitarian contexts, who make up a disproportionately high ...

Tags Vaccines WHO Executive Board

Antimicrobial resistance (AMR) is a major public health threat. Low- and middle-income countries are often hit the hardest.

Statement |

22 January 2024

MSF statement on EB 154/13 - Antimicrobial resistance (AMR): accelerating national and global responses

Médecins Sans Frontières faces serious challenges preventing, diagnosing and treating drug-resistant infections. A decisive strategy with ambitious, context-specific targets is needed to urgently address the situation. We call on ...

Tags Antimicrobial resistance WHO Executive Board

MSF Medical Doctor Ramya, conducting physical examination of female DRTB patient during her follow-up visit to endTB clinic.

Statement |

22 January 2024

MSF statement on EB154/10 - End TB Strategy

The WHO report on the End TB Strategy reminds us of the deadly impact of tuberculosis (TB), which kills over one million people per year, and how the most vulnerable populations, like children and people affected by drug-resistant TB ...

Tags Tuberculosis tuberculosis WHO Executive Board

Yusufa Adam, 5 years, received treatment for noma in the Sokoto hospital.

Statement |

22 January 2024

MSF statement on EB 154/11 - Road map for neglected tropical diseases 2021-2030

The road map implementation report rightly notes the progress made against neglected tropical diseases (NTDs). However, the decrease in the global burden of NTDs has been limited since 2015, and over 200,000 deaths are still caused ...

Tags Tropical & neglected diseases WHO Executive Board

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination

Americas TB Coalition letter to Danaher to reduce the price of GeneXpert test

Sierra Leone: National TB Programme letter to Danaher to reduce the price of GeneXpert test

Belarus: National TB Programme letter to Danaher to reduce the price of GeneXpert test

Ebola treatments: How to make them accessible

MSF calls for emergency stockpile of Ebola treatments ten years after world’s deadliest outbreak

MSF response to signing of EFTA-India trade agreement

MSF Comments on intellectual property provisions in the final agreement of India-EFTA Agreement

Letter: Civil society calls on European Parliament to support global access to medical tools by removing export prohibition in Union compulsory license

EU must drop all intellectual property provisions that go beyond WTO requirements in trade negotiations with India, as recommended in today’s SIA report

The PASTEUR Act is not the way for the US government to address antimicrobial resistance

Pandemic Accord: MSF statement at INB8 plenary session

MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions

Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is

Colombia takes significant next step to expand people’s access to affordable HIV treatment, and moves forward with compulsory license for HIV medicine dolutegravir

Diagnosing Paediatric TB: Challenges and Needs

MSF statement on EB 154/9 - Immunization Agenda 2030

MSF statement on EB 154/13 - Antimicrobial resistance (AMR): accelerating national and global responses

MSF statement on EB154/10 - End TB Strategy

MSF statement on EB 154/11 - Road map for neglected tropical diseases 2021-2030